🔵 THE IMMUNE BALANCE PROFILE
Men have lower MS relapse rates than women — and androgen signaling is part of the reason. Testosterone promotes oligodendrocyte survival and remyelination, directly protecting the myelin sheath under attack in MS. Sicotte et al. (2007) showed testosterone therapy in RRMS men reduced brain atrophy rate on MRI.
The Immune Balance stack addresses the nutritional foundation for neuroprotection, immune modulation, and hormonal support — while respecting the complexity of MS management. All compounds are coordinated to complement, not conflict with, disease-modifying therapy.
Build my protocol — freeTHE MECHANISM
“Men with RRMS treated with testosterone gel showed significant reduction in brain atrophy rate compared to the pre-treatment baseline — with cognitive performance improvements in spatial memory — suggesting direct neuroprotective effects of androgen signaling in MS.”
Sicotte NL et al., Archives of Neurology (2007) — pilot RCT, n=10 men with RRMS
Testosterone receptors are expressed in oligodendrocytes — the cells that produce myelin. Testosterone promotes oligodendrocyte differentiation and survival, and reduces the apoptotic response to inflammatory insult. The neuroprotective case for maintaining testosterone in physiological range in MS men is stronger than the general population.
IMMUNE BALANCE STACK
The most evidence-backed nutritional intervention in MS. Latitude correlates with MS prevalence globally; low vitamin D predicts relapse rate and is associated with greater brain lesion volume. MS guidelines at major academic centers support 5000 IU/day; target serum 25(OH)D of 50–80 ng/mL. Monitor levels every 6 months.
EPA and DHA reduce neuroinflammation via resolution pathways (resolvins, protectins) in CNS tissue. DHA is a structural component of neuronal membranes. Higher dose (3g) for neuroprotective purposes reflects MS-specific clinical context; Ascherio A et al. showed inverse correlation between omega-3 intake and MS risk.
Zinc modulates T-regulatory cell function and reduces autoimmune inflammatory signaling. In MS, immune dysregulation involves breakdown of regulatory pathways that normally suppress autoimmune attack. Zinc deficiency is common in men with inflammatory conditions and is a cofactor in testosterone synthesis — supporting the hormonal axis simultaneously.
Mitochondrial dysfunction is a feature of MS neurodegeneration — CoQ10 is the primary electron carrier in mitochondrial ATP production. MS fatigue is partly mitochondrial in origin. AM dosing with food for lipid-soluble absorption.
Precursor to glutathione — the CNS' primary endogenous antioxidant. Oxidative stress is a driver of MS demyelination. NAC replenishes glutathione in CNS tissue and reduces microglial inflammatory activation. PM timing reduces GI sensitivity.
MS-related spasticity, muscle cramping, and sleep disruption are all partially magnesium-responsive. PM glycinate supports GABA receptor function, reduces spasm frequency during sleep, and supports overnight testosterone synthesis via deep sleep architecture.
MS-related fatigue is one of the most debilitating symptoms and is not simply sleep-related — it has neuroimmune mechanisms. KSM-66 reduces inflammatory cytokines (IL-6, TNF-alpha) and supports HPA normalization. PM timing allows overnight cortisol reset. Check with your neurologist before use.
MEDICAL NOTE
Vitamin D at 5000 IU requires 25(OH)D monitoring every 6 months (target 50–80 ng/mL). High-dose omega-3 may interact with blood thinners. Always coordinate supplement changes with your neurologist, particularly if you are on or starting disease-modifying therapy.
“My neurologist was already recommending vitamin D — the Immune Balance stack gave me the full context for why, and filled in the pieces she wasn't covering. My fatigue score is the best it's been in three years.”
Greg S., 47
IMMUNE BALANCE PROFILE
COMMON QUESTIONS
FOUNDING MEMBERS
$39/mo Essential or $69/mo Full Protocol — price locked forever.